Skip To Main Content
Fiona Dunbar on Muck Rack

Fiona Dunbar

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fiona

Contact Fiona, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Psychological change processes in alcohol use disorder: A qualitative study of 5-methoxy- N , N -dimethyltryptamine (5-MeO-DMT) with cognitive behavioural therapy

|
By Mathieu Seynaeve, Fiona Dunbar, Beckley Psytech Oxford
| Wiley Online Library Verified
INTRODUCTION Alcohol use disorder (AUD) [Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)] is a major global public health challenge, with high prevalence, and substantial associated morbidity and mortality. In the United States, the 12-month prevalence of AUD is 16.7% for men and 10.4% for women [1]. In the United Kingdom (UK), the corresponding 12-month prevalence for alcohol dependence is approximately 6% for men and 2% for women [2].
Open in Who Shared Issue with article?

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

|
By John Marsden, South London, Michael Kelleher, Fiona Dunbar
| Wiley Online Library Verified
INTRODUCTION Harmful alcohol consumption and alcohol use disorder (AUD) are major global public health concerns, associated with approximately 5% of the global burden of disease [1, 2]. In addition to the direct negative health impacts, AUD contributes to a high burden of mental health comorbidities, including depression, anxiety and increased risk of suicide [3]. In a meta-analysis of 33 studies from 2022, alcohol use was associated with a 94% increase in the risk of death by suicide [4].
Open in Who Shared Issue with article?

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

|
By John Marsden, South London, Michael Kelleher, Fiona Dunbar
| buff.ly
INTRODUCTION Harmful alcohol consumption and alcohol use disorder (AUD) are major global public health concerns, associated with approximately 5% of the global burden of disease [1, 2]. In addition to the direct negative health impacts, AUD contributes to a high burden of mental health comorbidities, including depression, anxiety and increased risk of suicide [3]. In a meta-analysis of 33 studies from 2022, alcohol use was associated with a 94% increase in the risk of death by suicide [4].
Open in Who Shared Issue with article?
See all 3 articles